NGNE Neurogene Inc.
Healthcare$27.10-2.20%ClosedMarket Cap: $428.2M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$69.00
Target (Median)
$69.00
Target Range
$69.00 - $69.00
Upside from current price: 154.6%
Rating Distribution
0 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-06 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-01-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-12 | BMO Capital | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-5.10 | $462.5K | 5 |
| Fri Dec 31 | $-5.53 | $0.00 | 5 |
| Sun Dec 31 | $-4.79 | $66.6M | 5 |
| Mon Dec 31 | $-1.85 | $138.0M | 1 |